Terms ending in 2028
Every in-force patent on ZymoGenetics Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,790,163 | Antibodies That Bind Both IL-17A and IL-17F and Methods of Using the Same In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 7,799,323 | Methods of Using IL-31 to Treat Airway Hyper-Responsiveness and Asthma In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 7,790,676 | Soluble IL-17RA/RC Fusion Proteins In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 8,084,231 | Soluble IL-17RA/RC Fusion Proteins and Related Methods In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 8,242,072 | Methods of Treating Inflammation Using Soluble IL-17RA/RC Fusion Proteins In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 7,910,540 | Soluble ZCYTOR14, ANTI-ZCYTOR14 Antibodies and Binding Partners and Methods of Using in Inflammation In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 7,883,700 | Anti-Human IL-21 Monoclonal Antibodies In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 8,124,089 | Anti-Human IL-21 Monoclonal Antibodies In force · Medium confidence | ZymoGenetics, Inc. | In force | Medium confidence | |
| US 8,226,948 | Anti-Human IL-21 Monoclonal Antibodies In force · Medium confidence | ZymoGenetics, Inc. | In force | Medium confidence | |
| US 8,361,470 | Methods of Treatment Using Anti-Human IL-21 Monoclonal Antibodies In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| 6 more term ends in 2028 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16, including 5 expiring within the 18 months from Nov 18, 2026.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.